Luc Therapeutics acquires Ataxion for ion channel ataxia program
Luc Therapeutics Inc. (formerly Mnemosyne Pharmaceuticals) acquired private orphan CNS disease start-up Ataxion Inc.
- Acquisition of Private Biotech
- Full Acquisition
- Intra-Biotech Deal
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.